Welcome to LookChem.com Sign In|Join Free

CAS

  • or

41621-49-2

Post Buying Request

41621-49-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41621-49-2 Usage

Originator

Batrafen ,Cassella-Riedel, W. Germany ,1980

Uses

Different sources of media describe the Uses of 41621-49-2 differently. You can refer to the following data:
1. Ciclopirox (C432800) derivative. Broad spectrum antimycotic agent with some antibacterial activity.
2. Ciclopirox olamine (Loprox, Penlac) is a synthetic, broad-spectrum hydroxypyridone antifungal agent. It is chemically unrelated to the imidazoles or any other antifungal agent currently available in the United States. It appears to act through intracellular depletion of substrates and/or ions principally by inhibition of transmembrane transport of these substances. It is active against dermatophytes, yeast, and Pityrosporum orbiculare. It also demonstrates activity against Trichomonas vaginalis, some mycoplasma, and some gram-positive and gram-negative bacteria.
3. Ciclopirox ethanolamine is a broad spectrum antimycotic agent with some antibacterial activity.

Definition

ChEBI: The ethanolamine salt of ciclopirox. A broad spectrum antigfungal agent, it also exhibits antibacterial activity against many Gram-positive and Gram-negative bacteria, and has anti-inflammatory properties. It is used a a topical treatment of fungal skin an nail infections.

Indications

Ciclopirox olamine (Loprox, Penlac) is a synthetic, broad-spectrum hydroxypyridone antifungal agent. It is chemically unrelated to the imidazoles or any other antifungal agent currently available in the United States. It appears to act through intracellular depletion of substrates and/or ions principally by inhibition of transmembrane transport of these substances. It is active against dermatophytes, yeast, and Pityrosporum orbiculare. It also demonstrates activity against Trichomonas vaginalis, some mycoplasma, and some gram-positive and gram-negative bacteria.

Manufacturing Process

Ciclopirox may be produced as follows: 2 g of 4-methyl-6-cyclohexyl-2-pyrone were heated with 1 g of hydroxylamine hydrochloride and 5 g of 2-aminopyridine to 80 C for 8 hours. The reaction mixture was then dissolved in methylene chloride, the amine was removed by shaking with dilute hydrochloric acid, the reaction product was extracted from the organic phase by means of dilute sodium hydroxide solution and the alkaline solution was acidified with acetic acid to a pH value of 6. The 1-hydroxy-4-cnethyl-6-cyclohexyl-2-pyridone precipitated in crystalline form. It was filtered off with suction, washed with water and dried. The yield was 1.05 g (49% of theory); melting point 143 C. Reaction of ciclopirox with ethanolamine gives the desired prod

Brand name

Loprox (Hoechst- Roussel).

Therapeutic Function

Antifungal

Biological Activity

ciclopirox ethanolamine, working as an iron chelator, suppresses a substantial number of clinically relevant dermatophytes, yeasts, and molds, including the frequently azole-resistant candida species candida glabrata, candida krusei, and candida guilliermondii. moreover, ciclopirox has been proved to inhibit a wide range of bacteria in humans, including many gram-positive and gram-negative species pathogenic bacteria. [1]

Clinical Use

Different sources of media describe the Clinical Use of 41621-49-2 differently. You can refer to the following data:
1. 6-Cyclohexyl-1-hydroxyl-4-methyl-2(1H)-pyridinoneethanolamine salt (Loprox) is a broad-spectrum antifungalagent intended only for topical use. It is active against dermatophytesas well as pathogenic yeasts (C. albicans) thatare causative agents for superficial fungal infections.Ciclopirox is considered an agent of choice in the treatmentof cutaneous candidiasis, tinea corporis, tinea cruris,tinea pedis, and tinea versicolor. It is a second-line agent forthe treatment of onychomycosis (ringworm of the nails).Loprox is formulated as a cream and a lotion, each containing1% of the water-soluble ethanolamine salt. Ciclopirox isbelieved to act on cell membranes of susceptible fungi atlow concentrations to block the transport of amino acids intothe cells. At higher concentrations, membrane integrity islost, and cellular constituents leak out.
2. Ciclopirox olamine (Loprox) is a pyridone derivative available for the treatment of cutaneous dermatophyte infections, cutaneous C. albicans infections, and tinea versicolor caused by Malassezia furfur. It interferes with fungal growth by inhibiting macromolecule synthesis.

Safety Profile

Poison by intravenous andintraperitoneal routes. Moderately toxic by ingestion andsubcutaneous routes. Experimental reproductive effects.When heated to decomposition it emits toxic fumes ofNOx.

in vitro

ciclopirox inhibited dermatophytes and yeasts pathogenic with mics of 0.98-3.9 μg/ml. studies from c. albicans cells demonstrated that after being rapidly absorbed, ciclopirox largely accumulated intracellular with a concentration of 200 times greater than those in the medium. high concentration of ciclopirox resulted in the loss of folin-positive substances and potassium ions, by this way this agent could lead to cellular leakage without breaking the cell wall. similarly, by decreasing the uptake of precursors of the macromolecules or by decreasing the uptake of essential ions such as potassium ions and phosphate, ciclopirox blocked the synthesis of protein, rna, and dna in growing fungal cells. the chelation of metal ions and the suppression of iron-dependent enzymes were crucial for ciclopirox to exert antifungal effects. ciclopirox alone intensively suppressed the growth of aspergillus fumigatus b5233 conidia. ciclopirox also exhibited synergistic antifungal effect when being combined used with ketoconazole. [1]

in vivo

the effect of ciclopirox on endogenous hif-1 target gene-vegf was investigated using different animal organ models including mouse skin wound model, rat kidney model and chicken chorioallantoic membrane model. according to the results, cpx functionally activated hif-1, induced vegf expression and accelerated angiogenesis. [2]

IC 50

ciclopirox ethanolamine, a broad-spectrum antifungal agent, inhibits dermatophytes and yeasts pathogenic with a minimal inhibitory concentration (mic) of 0.98-3.9 μg/ml.

references

[1]niewerth m, kunze d, seibold m, schaller m, korting hc and hube b. ciclopirox olamine treatment affects the expression pattern of candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. antimicrob agents chem. 2003 jun; 47(6): 180517. [2]linden t, katschinski dr, eckhardt k, scheid a, pagel h and wenger rh. the antimycotic ciclopirox olamine induces hif-1 stability, vegf expression, and angiogenesis. faseb. 2003 feb; 17: 761–3.[3]subissi a, monti d, togni g and mailland f. recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. drugs. 2010 nov; 70(16): 2133-52.

Check Digit Verification of cas no

The CAS Registry Mumber 41621-49-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,6,2 and 1 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 41621-49:
(7*4)+(6*1)+(5*6)+(4*2)+(3*1)+(2*4)+(1*9)=92
92 % 10 = 2
So 41621-49-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2.C2H7NO/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10;3-1-2-4/h7-8,10,15H,2-6H2,1H3;4H,1-3H2

41621-49-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1134030)  Ciclopiroxolamine  United States Pharmacopeia (USP) Reference Standard

  • 41621-49-2

  • 1134030-125MG

  • 3,646.89CNY

  • Detail
  • Sigma-Aldrich

  • (C0415)  Ciclopiroxolamine  analytical standard

  • 41621-49-2

  • C0415-1G

  • 647.01CNY

  • Detail
  • Sigma-Aldrich

  • (C0415)  Ciclopiroxolamine  analytical standard

  • 41621-49-2

  • C0415-5G

  • 2,122.38CNY

  • Detail

41621-49-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name ciclopirox olamine

1.2 Other means of identification

Product number -
Other names 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolammonium salt

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41621-49-2 SDS

41621-49-2Synthetic route

CICLOPIROX
29342-05-0

CICLOPIROX

ethanolamine
141-43-5

ethanolamine

cyclopirox olamine
41621-49-2

cyclopirox olamine

Conditions
ConditionsYield
In ethyl acetate at 50℃; for 0.5h;
3-Methylbutenoic acid
541-47-9

3-Methylbutenoic acid

cyclopirox olamine
41621-49-2

cyclopirox olamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sulfuric acid / 5 h / Reflux
2.1: aluminum (III) chloride / dichloromethane / 3 h / Reflux
2.2: 20 h / 20 - 30 °C
2.3: 1 h / 20 °C
3.1: ethyl acetate / 0.5 h / 50 °C
View Scheme
Cyclohexanecarboxylic acid
98-89-5

Cyclohexanecarboxylic acid

cyclopirox olamine
41621-49-2

cyclopirox olamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: pyridine; thionyl chloride / 3 h / Reflux
2.1: aluminum (III) chloride / dichloromethane / 3 h / Reflux
2.2: 20 h / 20 - 30 °C
2.3: 1 h / 20 °C
3.1: ethyl acetate / 0.5 h / 50 °C
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

CICLOPIROX
29342-05-0

CICLOPIROX

Conditions
ConditionsYield
With hydrogenchloride In water84%
With hydrogenchloride In water; ethyl acetate84%
cyclopirox olamine
41621-49-2

cyclopirox olamine

di-tert-butyl (((6-cyclohexyl-4-methyl-2-oxopyridin-1(2H)-yl)oxy)methyl) phosphate

di-tert-butyl (((6-cyclohexyl-4-methyl-2-oxopyridin-1(2H)-yl)oxy)methyl) phosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil / 2.5 h / 0 - 20 °C
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / water
2: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
3: palladium on activated charcoal; hydrogen / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
View Scheme
Multi-step reaction with 4 steps
1: hydrogenchloride / water
2: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
3: palladium on activated charcoal; hydrogen / tetrahydrofuran
4: sodium cation
View Scheme
Multi-step reaction with 4 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
4: sodium cation
View Scheme
Multi-step reaction with 5 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
4: sodium carbonate / water; acetonitrile
5: sodium cation
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl dihydrogen phosphate

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl dihydrogen phosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / water
2: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
3: palladium on activated charcoal; hydrogen / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
View Scheme
Multi-step reaction with 4 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
4: sodium carbonate / water; acetonitrile
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

tert-butyl (((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl) hydrogen phosphate

tert-butyl (((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl) hydrogen phosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / water
2: sodium hydride / 2.5 h / 0 - 20 °C
3: sodium carbonate / water; acetonitrile
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

dibenzyl (((6-cyclohexyl-4-methyl-2-oxopyridin-1(2H)-yl)oxy)methyl) phosphate

dibenzyl (((6-cyclohexyl-4-methyl-2-oxopyridin-1(2H)-yl)oxy)methyl) phosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride / water
2: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil; N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

A

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl dihydrogen phosphate

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl dihydrogen phosphate

B

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil / 2.5 h / 0 - 20 °C
3: tetrahydrofuran; dichloromethane / 2 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil; N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
3: palladium on activated charcoal; hydrogen / tetrahydrofuran / 3 h / 20 °C
View Scheme
cyclopirox olamine
41621-49-2

cyclopirox olamine

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

((6-cyclohexyl-4-methylpyridin-1(2H)-yl)oxy)methyl phosphate disodium salt

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil / 2.5 h / 0 - 20 °C
3: tetrahydrofuran; dichloromethane / 2 h / 20 °C
4: sodium
View Scheme
Multi-step reaction with 4 steps
1: hydrogenchloride / water; ethyl acetate
2: sodium hydride / mineral oil; N,N-dimethyl-formamide / 1.5 h / 0 - 20 °C
3: palladium on activated charcoal; hydrogen / tetrahydrofuran / 3 h / 20 °C
4: sodium
View Scheme

41621-49-2Downstream Products

41621-49-2Relevant articles and documents

Synthesis method of ciclopirox olamine

-

, (2017/12/29)

The invention discloses a synthesis method of ciclopirox olamine. The synthesis method includes following steps: (1), preparing dimethyl methacrylate; (2), preparing cyclohexane formyl chloride; (3), preparing 5-oxo-3-methyl-5-cyclohexyl-3-methyl pentenoate; (4), preparing 1-hydroxy-4-methyl-6-cyclohexyl-2(1H)-pyridone; (5), preparing 1-hydroxy-4-methyl-6-cyclohexyl-2(1H)-pyridone-2-amino-ethylate ciclopirox olamine. The synthesis method has the advantages of high yield, high product quality, low running cost, automatic running of equipment, high stability and easiness in meeting industrial needs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 41621-49-2